Article

Country response to HIV/AIDS: national health accounts on HIV/AIDS in Brazil, Guatemala, Honduras, Mexico and Uruguay.

Fundación Mexicana para la Salud, A.C. (FUNSALUD), Regional AIDS Initiative for Latin America and the Caribbean (SIDALAC), Mexico, DF Mexico.
AIDS (Impact Factor: 6.56). 01/2003; 16 Suppl 3:S66-75.
Source: PubMed

ABSTRACT National expenditures on HIV/AIDS were estimated as summary indicators to assess the country's response to HIV/AIDS. The methodology is based on a matrix system describing the level and flow of health expenditures on HIV/AIDS: an adaptation of the National Health Accounts methods. The expenditures were classified by source (public, private, international), by the use of funds (prevention, care), by object, and by type of provider institution. The results are reported in US dollars using the official exchange rate for the year of estimation. For international comparisons monetary units were adjusted by the purchasing power parity (US dollars PPP). National HIV/AIDS total expenditures were: Guatemala US dollars PPP29.5 million, Uruguay US dollars PPP 32.5 million, Mexico US dollars PPP 257 million, and Brazil US dollars PPP 587.4 million during 1998, and Honduras US dollars PPP 33.9 million for 1999. The total HIV/AIDS expenditures per capita for 1998 were: Brazil US dollars 2.69, Mexico US dollars 1.25, Guatemala US dollars 1.08, Uruguay US dollars 6.63, and Honduras US dollars 3.6 for 1999. The 1998 distribution of the total HIV/AIDS expenditures in prevention and care were, respectively, Brazil 10 and 80%, Guatemala 15 and 70%, Mexico 29 and 66%, Uruguay 36 and 51%, and Honduras 28 and 65% for 1999. The share of total expenditures on antiretroviral drugs ranged from 52% in Guatemala to 75% in Brazil, even when the estimated coverage of antiretroviral therapy was close to 10% in Guatemala and universal in Brazil. The estimated flow from international sources per capita in 1998 was Uruguay US dollars 0.03, Brazil US dollars 0.24, Guatemala US dollars 0.11, Mexico US dollars 0.01, and Honduras US dollars 1.04 in 1999. The data allow international comparisons and provide critical information to improve equity and efficiency in the allocation of scarce resources. The National HIV/AIDS Accounts also constitute a powerful tool to describe the country's response to HIV/AIDS.

0 Followers
 · 
142 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A infecção pelo HIV em presidiários alcança uma das maiores prevalências entre subgrupos populacionais específicos, com taxas de até 17% já tendo sido descritas no Brasil e no mundo. Contribuem para isso diversos comportamentos de risco, adotados já antes do encarceramento ou desenvolvidos durante o período de reclusão. Entre eles, destacam-se o uso de drogas ilícitas intravenosas, compartilhamento de agulhas e seringas e atividade sexual desprotegida. Esta pesquisa objetivou estimar a prevalência do marcador do HIV e fatores de risco para esta infecção na população masculina carcerária da Penitenciária de Ribeirão Preto-SP, no período de maio a agosto de 2003. Do total de 1030 presidiários, foram sorteados 333 participantes por amostragem casual simples, os quais foram submetidos à aplicação de um questionário padronizado e tiveram coletada uma amostra de sangue. Para diagnóstico sorológico do HIV foi utilizado inicialmente o ensaio imunoenzimático (ELISA), como teste de triagem, com a confirmação sendo feita através de reação de imunofluorescência indireta (IFI). A prevalência global encontrada para o HIV nos presidiários foi de 5,7% ('IC IND. 95%': 3,2 - 8,2). Todas as variáveis que mostraram associação com a presença do anti-HIV, através de análise univariada, foram submetidas a um modelo multivariado de regressão logística utilizando o método Baysiano. Nesta análise, as variáveis que se mostraram preditoras de forma in. Dissertação (Mestrado).
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: UNAIDS has recognized that estimating HIV infection at a national or regional level is important for evaluation, program planning and advocacy. Following this recommendation, the purpose of this study was to estimate the magnitude of HIV infection prevalence among adults from the general population using information from the National Health Survey (ENSA 2000), a probabilistic, multi-stage, stratified, cluster household survey conducted by the Mexican Ministry of Health between November 1999 and June 2000. Availability of information from the Seroepidemiological Survey conducted in 1987 allowed for the estimation of trends between the two surveys (1987-2000). MATERIAL AND METHODS: A total of 21 271 males and females 20 years or older included in the ENSA 2000 were randomly selected and studied for anti-HIV 1/2 IgG (ELISA), confirmed by immunoelectrotransference (WB), and for risk factors associated with HIV infection. Samples were processed in the National Institute of Public Health in 2005. RESULTS: Prevalence for HIV infection was 0.25%. The main factors associated with infection were younger ages, male gender, residence in the Federal District, college education or higher, and being single or divorced. CONCLUSIONS: Seroprevalence among adults shows a ten-fold increase as compared with the results of the national seroprevalence survey of 1987. Although the epidemic continues to be concentrated among men who have sex with men, results provide evidence of dissemination towards the heterosexual population.
    Salud publica de Mexico 01/2007; 49:s386-94. · 0.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objetivo. ONUSIDA ha reconocido que calcular la magnitud de la infección por VIH en los planos nacional o regional es importante desde el punto de vista de la evaluación, planeación de programas y supervisión. Al adoptar esta recomendación, el propósito de este trabajo fue cuantificar la magnitud de la infección en la población general adulta mexicana a partir de los datos consignados en la ENSA 2000, la cual permitió determinar la prevalencia de infección por VIH en la población general y los principales factores relacionados. La disponibilidad de datos de la Encuesta Seroepidemiológica proveyó además la oportunidad de conocer las tendencias en el periodo entre las dos encuestas (1987-2000). Material y métodos. Se seleccionó de manera aleatoria a 21 271 individuos de 20 años de edad o mayores, de ambos sexos, estudiados en la ENSA 2000 para IgG anti-VIH1/2 (ELISA), confirmados por inmunoelectrotransferencia, y los principales factores relacionados con seropositividad. Las muestras se procesaron en el Instituto Nacional de Salud Pública en 2005. Resultados. La prevalencia para anticuerpos anti-VIH-1 fue de 0.25%. Los principales factores vinculados con la infección fueron las edades más jóvenes, sexo masculino, vivir en el Distrito Federal, escolaridad de licenciatura o mayor y ser soltero, divorciado o separado. Conclusiones. La seroprevalencia en hombres adultos muestra un incremento de 10 veces en comparación con la encuesta nacional de 1987. Si bien la epidemia continúa concentrada en hombres que tienen relaciones sexuales con hombres, existe evidencia de diseminación a la población heterosexual.
    Salud publica de Mexico 01/2007; 49. DOI:10.1590/S0036-36342007000900010 · 0.94 Impact Factor
Show more